Details of the Drug Formulations

General Information of Drug (ID: DM1SV8I)

Drug Name
PHN-131 Drug Info
Synonyms
NALBUPHINE HYDROCHLORIDE; Nalbuphine HCL; Nubain; 23277-43-2; Nalbufina clorhidrato [Spanish]; Nalbuphine hydrochloride [USAN]; En 2234A; UNII-ZU4275277R; EN-2234A; EINECS 245-549-9; ZU4275277R; 17-(Cyclobutylmethyl)-4,5alpha-epoxymorphinan-3,6alpha,14-triol hydrochloride; Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, hydrochloride, (5-alpha,6-alpha)-; (5alpha,6alpha)-17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol hydrochloride; N-Cyclobutylmethyl-14-hydroxydihydronormorphine hydrochloride; Nalbuphine h
Indication
Disease Entry ICD 11 Status REF
Pain MG30-MG3Z Phase 2/3 [1]
Cross-matching ID
PubChem CID
5360733
ChEBI ID
CHEBI:7455
CAS Number
23277-43-2
TTD ID
D06ZXH
ACDINA ID
D01268

Full List of Drug Formulations Containing This Drug

Nalbuphine Hydrochloride 10mg/ml injectable
Company Formulation ID FDA Description
Par Pharm F23236 Sodium Citrate Hydrous; Citric Acid Anhydrous; Methylparaben; Propylparaben; Hydrochloric Acid; Sodium Chloride
------------------------------------------------------------------------------------

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029095)